News Daily News Risk Factor Control Worse in Women Than Men in ISCHEMIA Trial Todd Neale March 04, 2024
News Daily News DISCHARGE Data Reassure on Use of CCTA in Older Chest-Pain Patients Michael O'Riordan March 04, 2024
News Daily News Even After Multivessel or LM PCI, Routine Stress Testing Adds Nothing Yael L. Maxwell March 01, 2024
News Daily News Agent Coronary DCB Gets FDA Approval for In-Stent Restenosis L.A. McKeown March 01, 2024
News Daily News Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective Michael O'Riordan February 23, 2024
News Daily News PCI Radiation Reduction Intervention Scores Big in Michigan L.A. McKeown February 15, 2024
News Daily News CTO Diagnosed, Now What? European Experts Offer Advice on Revascularization Caitlin E. Cox February 09, 2024
News Daily News UK Cardiac Audit Reveals Some Good, Some ‘Appalling’ Trends in PCI L.A. McKeown February 06, 2024
News Daily News Obstructive CAD Can Be Left Alone Before TAVI, Observational Data Suggest Michael O'Riordan January 30, 2024
News Daily News New Machine Learning-Based Tool Predicts Individual Post-PCI Outcomes Yael L. Maxwell January 25, 2024
News Daily News Socioeconomics Mire Access to All AVR Options for Aortic Stenosis Yael L. Maxwell January 22, 2024
News Daily News New Scientific Statement Focuses on Below-the-Knee Technical Challenges L.A. McKeown January 19, 2024
News Daily News No Fasting Before Cath? Study Shows No Harm—and Happier Patients L.A. McKeown January 16, 2024
News Daily News Experts Warn of Looming Private Equity Interest in Cardiology Care Michael O'Riordan January 15, 2024
News Daily News No Benefit to P2Y12 Inhibitor Pretreatment in STEMI, Bern-PCI Data Confirm Yael L. Maxwell January 10, 2024
News Daily News Five Years Post-PCI, Clopidogrel Monotherapy Holds Up in STOPDAPT-2 Michael O'Riordan January 03, 2024
News Daily News AHA Details Cath Lab’s Role in Out of Hospital Cardiac Arrest Caitlin E. Cox January 02, 2024
News Daily News Two ‘Evidence-Based Pathways’ for Stable Angina: ORBITA-2 Editorial Michael O'Riordan December 27, 2023